EUVIMEDEUVIMED entdecken
Crossref

Bis-sulfonamido-2-phenylbenzoxazoles Validate the GroES/EL Chaperone System as a Viable Antibiotic Target

Jack Godek, Jared Sivinski, Edmond R Watson, Felicidad Lebario, Wenli Xu, Mckayla Stevens, Christopher J Zerio, Andrew J Ambrose iD, Xiaoyi Zhu iD, Carlee A Trindl, Donna D Zhang, Steven M Johnson iD und 2 weitere

Journal of the American Chemical Society · 31.07.2024 · 146 (30) · 20845-20856

DOI: 10.1021/jacs.4c05057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 23.07.2024. Verfasst von Jack Godek und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Department of Pharmacology and Therapeutics, Center for Inflammation Science and Systems Medicine, The Herbert Wertheim UF Scrip…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Chaperonin 10, Escherichia coli. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: NIGMS NIH HHS, NIEHS NIH HHS, National Institute of Environmental Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We recently reported on small-molecule inhibitors of the GroES/GroEL chaperone system as potential antibiotics against Escherichia coli and the ESKAPE pathogens but were unable to establish GroES/GroEL as the cellular target, leading to cell death. In this study, using two of our most potent bis-sulfonamido-2-phenylbenzoxazoles (PBZs), we established the binding site of the PBZ molecules using cryo-EM and found that GroEL was the cellular target responsible for the mode of action. Cryo-EM revealed that PBZ1587 binds at the GroEL ring-ring interface (RRI). A cellular reporter assay confirmed that PBZ1587 engaged GroEL in cells, but cellular rescue experiments showed potential off-target effects. This prompted us to explore a closely related analogue, PBZ1038, which is also bound to the RRI. Biochemical characterization showed potent inhibition of Gram-negative chaperonins but much lower potency of chaperonin from a Gram-positive organism, Enterococcus faecium. A cellular reporter assay showed that PBZ1038 also engaged GroEL in cells and that the cytotoxic phenotype could be rescued by a chromosomal copy of E. faecium GroEL/GroES or by expressing a recalcitrant RRI mutant. These data argue that PBZ1038's antimicrobial action is exerted through inhibition of GroES/GroEL, validating this chaperone system as an antibiotic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsChaperonin 10Escherichia coliChaperonin 60BenzoxazolesMicrobial Sensitivity TestsMolecular StructureEscherichia coli Proteins

Substanzen

Anti-Bacterial AgentsChaperonin 10Chaperonin 60BenzoxazolesEscherichia coli Proteins

Autor:innen und Institutionen

  • College of Medicine, Department of Pharmacology and Therapeutics, Center for Inflammation Science and Systems Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of F…
  • College of Pharmacy, Department of Pharmacology and Toxicology, The University of Arizona, 1703 E. Mabel Street, P.O. Box 210207, Tucson, Arizona 85721, United States.
  • Department of Integrative Structural and Computational Biology, Scripps Research, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Dr., Indianapolis, Indiana 46202, United States.
  • The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Center for Inflammation Science and Systems Medicine, 130 Scripps Way, Jupiter, Florida 33458, United States.

ORCID-Profile: Andrew J Ambrose, Xiaoyi Zhu, Steven M Johnson, Eli Chapman

Förderung

  • NIGMS NIH HHS
  • NIEHS NIH HHS
  • National Institute of Environmental Health Sciences
  • National Institute of General Medical Sciences

Zitieren

APA

Godek, J., Sivinski, J., Watson, E. R., Lebario, F., Xu, W., Stevens, M., Zerio, C. J., Ambrose, A. J., Zhu, X., Trindl, C. A., Zhang, D. D., Johnson, S. M., Lander, G. C., & Chapman, E. (2024). Bis-sulfonamido-2-phenylbenzoxazoles Validate the GroES/EL Chaperone System as a Viable Antibiotic Target. Journal of the American Chemical Society, 146(30), 20845-20856. https://doi.org/10.1021/jacs.4c05057

Vancouver

Godek J, Sivinski J, Watson ER, Lebario F, Xu W, Stevens M, et al. Bis-sulfonamido-2-phenylbenzoxazoles Validate the GroES/EL Chaperone System as a Viable Antibiotic Target. Journal of the American Chemical Society. 2024;146(30):20845-20856. doi:10.1021/jacs.4c05057

BibTeX
@article{Godek2024,
  author = {Godek, Jack and Sivinski, Jared and Watson, Edmond R and Lebario, Felicidad and Xu, Wenli and Stevens, Mckayla and Zerio, Christopher J and Ambrose, Andrew J and Zhu, Xiaoyi and Trindl, Carlee A and Zhang, Donna D and Johnson, Steven M and Lander, Gabriel C and Chapman, Eli},
  title = {Bis-sulfonamido-2-phenylbenzoxazoles Validate the GroES/EL Chaperone System as a Viable Antibiotic Target},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  volume = {146},
  number = {30},
  pages = {20845--20856},
  doi = {10.1021/jacs.4c05057}
}
Kostenlos starten →